ALEXIS MITCHELL: Open Payments
NPI 1316645377 · FORT PAYNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 15 payments from 10 companies in 2025. Trend: 2023 $36 · 2024 $84 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| ABBVIE INC. | 2 | $38 |
| Amgen Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: TRELEGY ELLIPTA, CAPLYTA, VRAYLAR, ELIQUIS, Rybelsus, Kerendia, REPATHA, MOUNJARO.
Industry payments across AL — which companies pay providers there.
